Issue 8/2016
Content (9 Articles)
Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
- Current Opinion
Raffaele Califano, Ourania Romanidou, Giannis Mountzios, Lorenza Landi, Federico Cappuzzo, Fiona Blackhall
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
- Therapy in Practice
S. N. Salam, A. Khwaja, M. E. Wilkie
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
- Therapy in Practice
Philippe Moreau, Niels W. C. J. van de Donk, Jesus San Miguel, Henk Lokhorst, Hareth Nahi, Dina Ben-Yehuda, Michele Cavo, Gordon Cook, Michel Delforge, Hermann Einsele, Sonja Zweegman, Heinz Ludwig, Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld, María-Victoria Mateos
Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia
- Adis Drug Evaluation
Celeste B. Burness, Gillian M. Keating, Karly P. Garnock-Jones
Gabapentin Enacarbil: A Review in Restless Legs Syndrome
- Adis Drug Evaluation
Esther S. Kim, Emma D. Deeks
Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
- Adis Drug Evaluation
Lesley J. Scott
Erratum to: Management Strategies for Clopidogrel Hypersensitivity
- Erratum
Craig J. Beavers, Nicolas W. Carris, Kathryn M. Ruf